Article info

Download PDFPDF
Review
Clinical utility of cerebrospinal fluid biomarkers in the evaluation of cognitive impairment: a systematic review and meta-analysis

Authors

  1. Correspondence to Dr Jemma Hazan, University College London, London, UK; j.hazan{at}ucl.ac.uk
View Full Text

Citation

Hazan J, Wing M, Liu KY, et al
Clinical utility of cerebrospinal fluid biomarkers in the evaluation of cognitive impairment: a systematic review and meta-analysis

Publication history

  • Received May 4, 2022
  • Accepted August 29, 2022
  • First published September 12, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.